Balter Invenomic Annual Yield vs. Cash Position Weight

BIVRX Fund  USD 17.16  0.25  1.48%   
Based on the measurements of profitability obtained from Balter Invenomic's financial statements, Balter Invenomic Fund may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Balter Invenomic's ability to earn profits and add value for shareholders.
For Balter Invenomic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Balter Invenomic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Balter Invenomic Fund utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Balter Invenomic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Balter Invenomic Fund over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Balter Invenomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balter Invenomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balter Invenomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Balter Invenomic Cash Position Weight vs. Annual Yield Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Balter Invenomic's current stock value. Our valuation model uses many indicators to compare Balter Invenomic value to that of its competitors to determine the firm's financial worth.
Balter Invenomic Fund is rated below average in annual yield among similar funds. It is rated below average in cash position weight among similar funds creating about  2,853  of Cash Position Weight per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balter Invenomic's earnings, one of the primary drivers of an investment's value.

Balter Cash Position Weight vs. Annual Yield

Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Balter Invenomic

Yield

 = 

Income from Security

Current Share Price

 = 
0.02 %
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.

Balter Invenomic

Cash Percentage

 = 

% of Cash

in the fund

 = 
70.47 %
Funds or ETFs that have over 40% of their value invested in low-risk instruments or cash equivalents typically attract conservative investors.

Balter Cash Position Weight Comparison

Balter Invenomic is rated below average in cash position weight among similar funds.

Balter Invenomic Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Balter Invenomic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Balter Invenomic will eventually generate negative long term returns. The profitability progress is the general direction of Balter Invenomic's change in net profit over the period of time. It can combine multiple indicators of Balter Invenomic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years and in initial public offerings of securities .

Balter Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Balter Invenomic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Balter Invenomic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Balter Invenomic's important profitability drivers and their relationship over time.

Use Balter Invenomic in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Balter Invenomic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balter Invenomic will appreciate offsetting losses from the drop in the long position's value.

Balter Invenomic Pair Trading

Balter Invenomic Fund Pair Trading Analysis

The ability to find closely correlated positions to Balter Invenomic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Balter Invenomic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Balter Invenomic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Balter Invenomic Fund to buy it.
The correlation of Balter Invenomic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Balter Invenomic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Balter Invenomic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Balter Invenomic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Balter Invenomic position

In addition to having Balter Invenomic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Compulsion Thematic Idea Now

Compulsion
Compulsion Theme
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Balter Mutual Fund

To fully project Balter Invenomic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Balter Invenomic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Balter Invenomic's income statement, its balance sheet, and the statement of cash flows.
Potential Balter Invenomic investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Balter Invenomic investors may work on each financial statement separately, they are all related. The changes in Balter Invenomic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Balter Invenomic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Stocks Directory
Find actively traded stocks across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges